Bluejay Diagnostics Inc (BJDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,804 | -2,329 | -9,954 | -7,651 | -5,353 |
| Depreciation Amortization | 108 | 54 | 781 | 725 | 454 |
| Accounts payable and accrued liabilities | -1 | -220 | -236 | 19 | -430 |
| Other Working Capital | 156 | -38 | 667 | 1,184 | 239 |
| Other Operating Activity | 327 | 232 | 428 | 188 | 679 |
| Operating Cash Flow | $-4,215 | $-2,300 | $-8,314 | $-5,536 | $-4,411 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -305 | -35 | -704 | -616 | -542 |
| Investing Cash Flow | $-305 | $-35 | $-704 | $-616 | $-542 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 2,000 | N/A | N/A | N/A | 0 |
| Debt Repayment | -2 | -1 | -5 | -4 | -2 |
| Common Stock Issued | 12,069 | 3,500 | 1,177 | 1,591 | 0 |
| Other Financing Activity | -3,697 | -711 | -61 | -473 | -59 |
| Financing Cash Flow | $10,370 | $2,788 | $1,112 | $1,115 | $-62 |
| Beginning Cash Position | 2,209 | 2,209 | 10,115 | 10,115 | 10,115 |
| End Cash Position | 8,058 | 2,661 | 2,209 | 5,077 | 5,100 |
| Net Cash Flow | $5,850 | $453 | $-7,907 | $-5,038 | $-5,015 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,215 | -2,300 | -8,314 | -5,536 | -4,411 |
| Capital Expenditure | -305 | -35 | -704 | -616 | -542 |
| Free Cash Flow | -4,520 | -2,335 | -9,018 | -6,153 | -4,953 |